Even in the US, some controversy persists over the conceptual defensibility of brain death. Around the world, the philosophical defensibility of brain death is even more debatable. Watch as Dr. Qing Yang presents data regarding the adoption of brain death in China. She discusses cultural differences between Chinese and US medical professionals and patients that inform policy and law when it comes to brain death. Dr. Bob Truog, a prominent brain death critic, replies.
Thomas I. Cochrane, MD, MBA
Associate Neurologist and Senior Ethics Consultant, Brigham and Women’s Hospital
Assistant Professor of Neurology and Director of Neuroethics, Center for Bioethics, Harvard Medical School
Panel:
Qing Yang, MD, PhD
Department of Anesthesia, Massachusetts
General Hospital
Robert D. Truog, MD
Director, Center for Bioethics and Professor of Medical Ethics, Anaesthesiology & Pediatrics at Harvard Medical School
Senior Associate in Critical Care Medicine at Children’s Hospital Boston